JPMorgan Chase & Co’s Citius Pharmaceuticals CTXR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $191 | Sell |
120
-16
| -12% | -$25 | ﹤0.01% | 5895 |
|
|
2025
Q1 | $203 | Buy |
136
+12
| +10% | +$18 | ﹤0.01% | 5920 |
|
|
2024
Q4 | $496 | Buy |
124
+2
| +2% | +$8 | ﹤0.01% | 5748 |
|
|
2024
Q3 | $1.52K | Hold |
122
| – | – | ﹤0.01% | 5598 |
|
|
2024
Q2 | $1.78K | Sell |
122
-1,927
| -94% | -$28K | ﹤0.01% | 5526 |
|
|
2024
Q1 | $46K | Sell |
2,049
-1,141
| -36% | -$25.6K | ﹤0.01% | 5015 |
|
|
2023
Q4 | $60.3K | Hold |
3,190
| – | – | ﹤0.01% | 4958 |
|
|
2023
Q3 | $54.6K | Sell |
3,190
-731
| -19% | -$12.5K | ﹤0.01% | 4879 |
|
|
2023
Q2 | $118K | Buy |
3,921
+3,918
| +130,600% | +$118K | ﹤0.01% | 4565 |
|
|
2023
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 5844 |
|
|
2022
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 5620 |
|
|
2022
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 5558 |
|
|
2022
Q2 | $0 | Sell |
3
-2,325
| -100% | – | ﹤0.01% | 5627 |
|
|
2022
Q1 | $104K | Buy |
2,328
+581
| +33% | +$26K | ﹤0.01% | 4726 |
|
|
2021
Q4 | $67K | Sell |
1,747
-1,828
| -51% | -$70.1K | ﹤0.01% | 4975 |
|
|
2021
Q3 | $181K | Sell |
3,575
-2,568
| -42% | -$130K | ﹤0.01% | 4462 |
|
|
2021
Q2 | $535K | Buy |
+6,143
| New | +$535K | ﹤0.01% | 3951 |
|